Company · ABEO
Abeona Therapeutics Inc.
Name as listed on its exchange; filed with the SEC as ABEONA THERAPEUTICS INC.
Nasdaq's symbol directory lists ABEO on Nasdaq as “Abeona Therapeutics Inc. - Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($34K); insiders sold on 12 occasions ($1.3M); 4 planned-sale notices; 5 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Seshadri Vishwas, Chief Executive Officer sold $574K
- Vazzano Joseph Walter, Chief Financial Officer sold $230K
- O'Malley Brendan M., SVP, Chief Legal Officer sold $119K
- Vasanthavada Madhav, Chief Commercial Officer sold $113K
- Silverstein Christine Berni sold $104K
- Alvino Mark sold $88K
- Alland Leila sold $65K
- Faith L. Charles bought $34K
Every trade (13)
- BUYFaith L. Charles bought $34K
- SELLSeshadri Vishwas, Chief Executive Officer sold $101K
- SELLVazzano Joseph Walter, Chief Financial Officer sold $47K
- SELLO'Malley Brendan M., SVP, Chief Legal Officer sold $35K
- SELLVasanthavada Madhav, Chief Commercial Officer sold $25K
- SELLAlvino Mark sold $88K
- SELLVazzano Joseph Walter, Chief Financial Officer sold $10K
- SELLSeshadri Vishwas, Chief Executive Officer sold $473K
- SELLVazzano Joseph Walter, Chief Financial Officer sold $173K
- SELLVasanthavada Madhav, Chief Commercial Officer sold $88K
- SELLO'Malley Brendan M., SVP, Chief Legal Officer sold $84K
- SELLAlland Leila sold $65K
- SELLSilverstein Christine Berni sold $104K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Seshadri Vishwas $101K
- Vazzano Joseph Walter $47K
- O'Malley Brendan M. $35K
- Vasanthavada Madhav $25K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- TPG GP A, LLC 7%
- Funicular Funds, LP 7.5%
- Daniel Kaufman 7.3%
- James Russell Revocable Trust 6.1%
- Montanova Capital, LLC 0.9%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Results of operations and financial condition; Regulation FD disclosure Nov 9, 2026
- Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Unregistered sales of equity securities; Regulation FD disclosure Nov 9, 2026
- Regulation FD disclosure Sep 15, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.